Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neurodegeneration in a novel invertebrate model system: Failed microtubule-mediated cell adhesion and unraveling of macroglia.
Fabian-Fine R, Aiken AM, Aug JR, Boucher JD, Butler DC, Clancy LJ, Clem SA, Crotty SC, Dalpe AM, Donzello-Jewett EJ, Galgay TM, Gillis BK, Heinrich BW, Hines KR, Kimmel JE, McGrath JM, Miles MM, Morey JA, Ortiz IA, Pham KQ, Quinn LC, Radican CJ, Speidel NT, Thomas BJ, Troisi AR, Weiss JL, Wentzheimer KV, Weaver AL. Fabian-Fine R, et al. Among authors: weiss jl. J Comp Neurol. 2023 Apr;531(5):618-638. doi: 10.1002/cne.25450. Epub 2023 Jan 3. J Comp Neurol. 2023. PMID: 36594894 Free PMC article.
Immune cell subset profiling in multiple sclerosis after fingolimod initiation and continued treatment: The FLUENT study.
Mao-Draayer Y, Cohen JA, Bar-Or A, Han MH, Singer B, Williams IM, Meng X, Elam C, Weiss JL, Cox GM, Ziehn M, Cree BA; FLUENT study investigators. Mao-Draayer Y, et al. Among authors: weiss jl. Mult Scler J Exp Transl Clin. 2022 Aug 1;8(3):20552173221115023. doi: 10.1177/20552173221115023. eCollection 2022 Jul-Sep. Mult Scler J Exp Transl Clin. 2022. PMID: 35936922 Free PMC article.
A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying Therapies.
Burtchell J, Clemmons D, Clemmons J, Sabutis T, Rosenberg A, Graves J, Sweeney ML, Kramer J, Ziehn M, Brown B, Weiss JL, Obeidat AZ. Burtchell J, et al. Among authors: weiss jl. Neurol Ther. 2022 Sep;11(3):955-979. doi: 10.1007/s40120-022-00349-5. Epub 2022 May 24. Neurol Ther. 2022. PMID: 35608740 Free PMC article. Review.
188 results